Ocular Therapeutix Inc. | Mutual Funds
Mutual Funds that own Ocular Therapeutix Inc.
Fidelity Select Biotechnology Portfolio
2,394,399
6.2%
0
0.18%
07/31/2018
Prudential Jennison Health Sciences Fund
1,431,743
3.71%
0
0.38%
07/31/2018
Vanguard Total Stock Market Index Fund
747,776
1.94%
30,500
0%
07/31/2018
iShares Russell 2000 ETF
682,578
1.77%
-366
0.01%
09/06/2018
Vanguard Extended Market Index Fund
412,805
1.07%
0
0%
07/31/2018
Fidelity Advisor Biotechnology Fund
410,721
1.06%
-252,328
0.1%
07/31/2018
iShares Russell 2000 Growth ETF
318,544
0.83%
0
0.02%
09/06/2018
Fidelity Select Pharmaceuticals Portfolio
182,000
0.47%
0
0.16%
07/31/2018
Fidelity Spartan Extended Market Index Fund
145,435
0.38%
0
0%
07/31/2018
John Hancock - Seaport Fund
113,760
0.3%
0
0.15%
05/31/2018
| Address |
15 Crosby Drive
Bedford Massachusetts 01730
United States
|
|
Employees
|
- |
| Website |
http://www.ocutx.com |
| Updated |
07/08/2019 |
| Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. |
